Academic Journal
Q1Immunology
About Immunology
Immunology is a scholarly journal published by Wiley-Blackwell Publishing Ltd. SCImago 2025 lists it in Q1, with an SJR of 1.581 and H-index of 170.
Coverage: 1958-2026. Research categories: Immunology (Q1); Immunology and Allergy (Q1).
Verified field sources
- Editor(s): Greg Delgoffe (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
- Journal Impact Factor: 5.4 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
Source-backed journal facts
Topics in published research
Immune Cell Function and Interaction; T-cell and B-cell Immunology; Immunotherapy and Immune Responses; Immune Response and Inflammation; Monoclonal and Polyclonal Antibodies Research; Cancer Immunotherapy and Biomarkers.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
5,330.00 USD; 4,480.00 EUR; 3,570.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
The Role of Innate Lymphoid Cells in Autoimmune, Allergic and Infectious Diseases: A Systematic Review
Luan F. Lückmann, Henrique R. Dal‐Pizzol, Louise M. Lückmann, Davi E. Salini et al.
2026-09-30 · DOI: 10.1111/imm.70202The Interactions Between Acetylcholine and T‐Cells and Their Role in the Immune System: A Scoping Review
Jarita Lay, Nicholas Manolios
2026-09-30 · DOI: 10.1111/imm.70204A Multidimensional Framework for Interpreting Macrophage Markers in the Era of Cellular Heterogeneity
Alessandro Palma
2026-09-29 · DOI: 10.1111/imm.70208High‐Intensity Interval Training Modulates NLRP3 Inflammasome‐Related Expression and Monocyte Subset Distribution in Adults With Obesity: A Randomised Trial
Daniela A. de Abreu, Ana Luíza P. A. Silveira, Stella de S. Vieira, Francisco A. H. Fonseca et al.
2026-09-21 · DOI: 10.1111/imm.70206Linoleic Acid Enhances Murine Natural Killer Cell Function In Vitro but Compromises Mitochondrial Bioenergetic Function During Retroviral Infection
Vaasudevan Sridhar, Simone Schimmer, Tanja Werner, Rachel Giesen et al.
2026-09-20 · DOI: 10.1111/imm.70205RETRACTION : Interleukin‐1 and Interleukin‐6 Gene Expression in Human Monocytes Stimulated With Salmonella Typhimurium Porins
2026-09-16 · DOI: 10.1111/imm.70199Redistribution of CD73 Expression on CD4+T Subpopulations in Systemic Lupus Erythematosus and Its Association With Disease Activity
Rui Ma, Wen‐jie Yu, Yun‐xian Yang, Zhan‐hong Lai et al.
2026-09-13 · DOI: 10.1111/imm.70201Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti‐ PD ‐1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma
Haoyu Zhang, Jiaqi Tan, Xiaoqiao Cui, Xueying Wang et al.
2026-09-09 · DOI: 10.1111/imm.70196Evaluation of Methods for Identifying Human Monocytes by Flow Cytometry: TLR2 May be an Optimal Marker
Mie Wolff Kristensen, Katrine Skjøt Harbo, Thomas Vorup‐Jensen, Marianne Hokland et al.
2026-09-07 · DOI: 10.1111/imm.70195The Immune Rheostat: A Shared Regulatory Axis Linking Cancer Immune Evasion and Autoimmune Activation
Sivasangari Balakrishnan, Karthi Muthuswamy
2026-09-06 · DOI: 10.1111/imm.70198Issue Information
2026-10 · DOI: 10.1111/imm.70172Irradiation‐Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK
Estelle Leplus, Jamila Kacher, Dalil Hannani, Guillaume Vayssiere et al.
2026-09-02 · DOI: 10.1111/imm.70194Gut Epithelial AMPK / SIRT1 Signalling Is Associated With Akkermansia muciniphila ‐Linked Th17/Treg Reprogramming and Immune Homeostasis After Ischemic Stroke
Jianfeng Zheng, Zhihua Wu, Duxiang Lin, Minghui Fang et al.
2026-09-02 · DOI: 10.1111/imm.70191Elevations of Th17.1 Cells ( CXCR3 + CCR6 + T Cells With IL ‐ 17A and IFN ‐γ Production) in Peripheral Blood of Patients With Lung Cancer
Jiaoyun Lv, Wencheng Yin, Xialin Nie, Siyuan Chen et al.
2026-09-01 · DOI: 10.1111/imm.70197Single‐Cell Atlas Reveals Neutrophil Heterogeneity in Hypervirulent Klebsiella pneumoniae Infection‐Induced Sepsis
Xiang Fang, Weizhao Li, Xinyu Zhang, Sohana Akter Mina et al.
2026-08-27 · DOI: 10.1111/imm.70193Correction to ‘Newly Found Rat CD103 − Dendritic Cells Represent a Highly Immunogenic Subpopulation of Type‐2 Conventional Dendritic Cells, Corresponding to Known Dendritic Cell Subsets in Mice and Humans’
2026-08-18 · DOI: 10.1111/imm.70186Immune Regulation of CD36 in Cardiovascular Diseases
Yujie Zha, Lili Bao, Cong Bi, Bingqi Liu et al.
2026-08-17 · DOI: 10.1111/imm.70167Clinical Heterogeneity of TNFRSF13B Variants: A Monogenic Cause or a Genetic Modifier?
Begum Cicek, Deniz Ilgun Gurel, Ismail Yaz, Sevda Tuten Dal et al.
2026-08-14 · DOI: 10.1111/imm.70192Reviews
Community Reviews
Version History
September 25, 2026 at 7:26 am
September 25, 2026